Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background and study objective The standard of care for premalignant and malignant mucosal lesions in the gastrointestinal track with limited submucosal invasion is an endoscopic resection. A curative resection of the neoplasia often necessitates an en-bloc resection, where the resection ends within healthy tissue (R0 resection). Endoscopic submucosal dissection (ESD) is a highly sophisticated resection technique for lesions in the oesophagus, stomach, duodenum, colon and rectum. Multiple studies in Asia already established the safety and efficacy of ESD. In several spezialized centres in t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • signed consent form
- • Indication for an ESD in the oesophagus, stomach, duodenum, colon or rectum
- • Age \>18 years
- Exclusion Criteria:
- • Age \< 18 years
About Torsten Beyna
Torsten Beyna is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a commitment to ethical standards and regulatory compliance, Beyna orchestrates a diverse portfolio of clinical trials that span various therapeutic areas. By fostering collaborations with healthcare professionals, research institutions, and regulatory bodies, Torsten Beyna aims to accelerate the development of new therapies, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Düsseldorf, Nrw, Germany
Patients applied
Trial Officials
Torsten PD Dr. med Beyna
Principal Investigator
Evangelisches Krankenhaus Düsseldorf
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported